Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33)

The aim of this grant is to support research projects exploring the roles of biomolecular condensates (BMCs) and their regulators in processes relevant to HIV/SIV infection, replication, latency, or pathogenesis in the context of substance use disorders. These processes could include studies exploring BMC involvement in HIV infection, HIV replication, HIV latency formation or maintenance, or HIV pathogenesis. 

Funding: R21 $125,000 per year; R33 $250,000 per year 

Duration: R21 2 years; R33 3 years

Research Authority due date: 11.6.20

LOI (encouraged) due date: 20.6.20

Full proposal due date: 20.7.20